RXRX

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RXRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/20	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/20	05:27	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/18	05:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/17	19:03	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/13	07:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/12	06:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/11	06:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/07	05:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/06	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/06	00:43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/05	06:24	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/05	02:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/04	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/04	05:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/03	21:02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/03	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/09/03	21:00	GlobeNewswire Inc.	Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/31	05:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/30	05:53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/30	05:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/29	05:49	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/29	05:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/29	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/28	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/27	05:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/24	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/23	07:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/21	05:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/20	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/08/20	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc